Chronic Myeloproliferative Disorders Completed Phase 1 / 2 Trials for Cytarabine (DB00987)

IndicationStatusPhase
DBCOND0028462 (Chronic Myeloproliferative Disorders)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00003619Combination Chemotherapy Followed By Peripheral Stem Cell Transplantation or Isotretinoin in Treating Patients With Acute Myeloid Leukemia, Myelodysplastic Syndrome, or Acute Lymphocytic LeukemiaTreatment